Foundation Press

ImmusanT, Inc., has announced that its therapeutic vaccine candidate, Nexvax2, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

Laura Boone, 29, development manager for the Celiac Disease Foundation, was a senior in college when she was first diagnosed with celiac disease. No one could determine why she was feeling so sick.

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.

CEO of the Celiac Disease Foundation, Marilyn G. Geller was quoted in a recent Wine Spectator article discussing instances in which wine may come into contact with gluten.

How the Gluten-Free Craze Affects Celiac Patients